Making Science Accessible for All Through Collaboration Between Neuromuscular Researchers and Patient Partners!

By: Shatha Atieh

Building Bridges: Making Science Accessible for All Through Collaboration event series was created to promote inclusive, interdisciplinary and accessible scientific communication between trainee researchers (undergraduate, master’s and PhD students) and patient partner communities—elements that are often overlooked in traditional research environments. To address this, I co-created this event with another PhD candidate, Kelly Ho, with Linda Niksic and Angela Woolam, patient partners from our organizing committee, and Erin Beattie and James Davis from the NMD4C.

Too often, the research landscape prioritizes scientific innovation without focus on accessible scientific language. We aimed to address this gap by giving trainees the opportunity to present their research in plain language, ensuring patient partners are not just included, but central to the scientific conversation.

The first event in this series was held virtually on February 20th, 2025, and served as a foundational workshop for the in-person event in May. It introduced key principles of patient engagement in research and provided practical tools, resources and examples to help trainees translate complex scientific ideas into plain language. This was a critical step in ensuring that students were equipped to communicate their work clearly and meaningfully to patient partners during the upcoming in-person event in May.

The second event held on May 26th, 2025, brought these efforts to life. It featured presentations by one of the Building Bridges patient partner committee members, Angela Woollam, as well as a senior scientist, Dr Hanns Lochmüller, who spoke on the value of collaboration and mutual understanding. Trainees also delivered flash talks and presented their research during the poster session in plain language, fostering dialogue, mutual understanding and empowerment.

As a PhD student at the University of Ottawa, I found it essential to uphold the University of Ottawa’s Strategic Area of Research tenet, “Enabling Lifelong Health and Wellness”, particularly contributing to the Neuromuscular pillar of the Brain and Mind research theme. This includes promoting a collaborative, patient-centered environment that focuses on accessible scientific communication and mutual empowerment; patient partners at times feel left out of emerging and innovative research conversations—through this initiative, we aimed to change that.

By promoting collaborative, patient-centered research practices, Building Bridges contributes to the development of research that is more impactful and responsive to the needs of the communities it aims to serve. As a result, research outcomes are more likely to be understood, accepted, and thus, implemented leading to potential changes in existing clinical, research, and educational practices. This event could not have been accomplished without our insightful patient partners, Angela and Linda as well as our sponsors, the Neuromuscular Disease Network for Canada and the University of Ottawa’s Faculty of Medicine.

I am incredibly proud to be a part of an initiative that strives to reflect the kind of research culture that centers patient voices and fosters the kind of interdisciplinary collaboration that can lead to real transformative change and empowerment for both trainees and patient partners—not just in our labs, but in each other’s lives.

If anyone is interested in further details or assistance in holding similar events to foster collaboration between neuromuscular researchers and patient partners, please contact Erin Beattie at ebe

BUILDING BRIDGES EMAIL BANNER

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.